Jacobs Equity LLC

SEC CIK: 0002111761
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Jacobs Equity LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overview All 13F holders of CRSP Full Q2 2026 holdings

Shares (Q2 2026): 14,675
Value: $800.4K
% of portfolio: 0.6%
Quarters held: 3; Since Q4 2025

Holdings of CRSP by Jacobs Equity LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	14,675	$800.4K	0.6%	+3,085+26.6%	Added	Holders
Q1 2026	11,590	$551.3K	0.5%	−500−4.1%	Reduced	Holders
Q4 2025	12,090	$634.0K	0.6%	–	No prior filing	Holders